|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash and cash equivalents | ||||||
| Due from sponsor | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | ||||||
| Restricted Cash | ||||||
| Accounts Receivable, Net | ||||||
| Inventories | ||||||
| Prepaid Expenses | ||||||
| Other Current Assets | ||||||
| Total Current Assets | ||||||
| Long-term prepaid insurance | ||||||
| Marketable securities held in Trust Account | ||||||
| Long-Term Assets | ||||||
| Restricted Cash | ||||||
| Property, Plant, and Equipment, Net | ||||||
| Operating lease right of use assets, net | ||||||
| Goodwill | ||||||
| Intangible Asset, Finite-Lived, after Accumulated Amortization | ||||||
| Internally developed software | ||||||
| Trade names | ||||||
| Other Assets | ||||||
| Total Long-Term Assets | ||||||
| Total Assets | ||||||
| Liabilities and Stockholders’ Equity | ||||||
| Current Liabilities | ||||||
| Accounts Payable | ||||||
| Accrued Expenses | ||||||
| Accrued offering costs | ||||||
| Deferred Revenue | ||||||
| Contingent Consideration | ||||||
| Short-Term Debt and Current Portion of Long-Term Debt | ||||||
| Current portion of operating lease obligations | ||||||
| Other Current Liabilities | ||||||
| Total Current Liabilities | ||||||
| PIPE Subscription Agreements liability | ||||||
| Deferred advisory fee | ||||||
| Long-Term Liabilities | ||||||
| Warrant Liability | ||||||
| Contingent Consideration | ||||||
| Long-Term Debt, Net | ||||||
| Long-term operating lease obligations | ||||||
| Derivative liability, noncurrent | ||||||
| Earnout Shares and Deferred Founder Shares | ||||||
| Forward Purchase Agreement | ||||||
| Other Long-Term Liabilities | ||||||
| Total Long-Term Liabilities | ||||||
| Total Liabilities | ||||||
| Class A Ordinary Shares subject to possible redemption; 23,000,000 shares at redemption value of $10.48 and $10.39 per share as of March 31, 2026 and December 31, 2025, respectively | ||||||
| Redeemable Noncontrolling Interests | ||||||
| Stockholders’ Equity | ||||||
| Common Stock, $0.0001 par value, 450,000,000 shares authorized, 71,985,735 issued and outstanding as of June 30, 2026; 97,899,711 shares authorized, 49,180,937 shares issued and outstanding as of December 31, 2025 | ||||||
| Class B Ordinary Shares | ||||||
| Total common Stock, $0.0001 par value, 450,000,000 shares authorized, 71,985,735 issued and outstanding as of June 30, 2026; 97,899,711 shares authorized, 49,180,937 shares issued and outstanding as of December 31, 2025 | ||||||
| Additional Paid-In Capital | ||||||
| Accumulated Deficit | ||||||
| Accumulated Other Comprehensive Loss | ||||||
| Total Stockholders’ Equity | ||||||
| Noncontrolling Interests | ||||||
| Total Equity | ||||||
| Total Liabilities and Stockholders’ Equity |
Loading...
